Tag: iron

Articles

• Supplements with warnings for breast cancer

News

05/13/17

Iron protects breast cancer cells from natural killer cells

09/19/15

Ferritin can protect breast cancer cells from treatment by Adriamycin

09/28/14

Red meat consumption during adolescence linked to premenopausal BC

Foods

• • beef
  • cashews
  • caviar
  • chocolate
  • sesame seeds and sesame oil
  • shellfish
  • soy protein isolate
  • soybeans

Studies

• Abstract 430: Precision diet and lipid modulating agents to induce lipid oxidation in breast cancer Cite
  Yavari M, Torpey J, Sabatier M, Carmona A, Szylo K, Flores M, et al. Abstract 430: Precision diet and lipid modulating agents to induce lipid oxidation in breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:430-430 10.1158/1538-7445.am2024-430
• Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy Cite
  Khan F, Pandey P, Verma M, Ramniwas S, Lee D, Moon S, et al. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Biomedicine & Pharmacotherapy. Elsevier BV; 2024; 173:116363 10.1016/j.biopha.2024.116363
• Heavy metals in biological samples of cancer patients: a systematic literature review Cite
  Coradduzza D, Congiargiu A, Azara E, Mammani IMA, De Miglio MR, Zinellu A, et al. Heavy metals in biological samples of cancer patients: a systematic literature review. BioMetals. Springer Science and Business Media LLC; 2024; 10.1007/s10534-024-00583-4
• Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials Cite
  Wang J, Li J, Liu J, Chan K, Lee H, Lin KN, et al. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials. Cancers. MDPI AG; 2024; 16:512 10.3390/cancers16030512
• Design of Tetrazolium Cations for the Release of Antiproliferative Formazan Chelators in Mammalian Cells Cite
  Xu Z, Sung Y, Tomat E. Design of Tetrazolium Cations for the Release of Antiproliferative Formazan Chelators in Mammalian Cells. Journal of the American Chemical Society. American Chemical Society (ACS); 2023; 145:15197-15206 10.1021/jacs.3c02033
• Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation Cite
  Zhou X, Guo X, Han J, Wang M, Liu Z, Ren D, et al. Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation. Experimental Cell Research. Elsevier BV; 2023; 431:113760 10.1016/j.yexcr.2023.113760
• Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines Cite
  Abdelaal G, Carter A, Cheung W, Panayiotidis M, Racey S, Tétard D, et al. Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines. Biomedicines. MDPI AG; 2023; 11:2073 10.3390/biomedicines11072073
• A Novel Ferroptosis-Related Gene Signature for Chemotherapy Resistance Prediction in Triple-negative Breast Cancer Cite
  You H, Qian H, Miao S, Li X, Liu B, Zhang D, et al. A Novel Ferroptosis-Related Gene Signature for Chemotherapy Resistance Prediction in Triple-negative Breast Cancer. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3176896/v1
• Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly Cite
  McQuilten ZK, Thao LTP, Pasricha S, Artz AS, Bailey M, Chan AT, et al. Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly. Annals of Internal Medicine. American College of Physicians; 2023; 10.7326/m23-0675
• Iron Metabolism in Cancer and Senescence: A Cellular Perspective Cite
  Crescenzi E, Leonardi A, Pacifico F. Iron Metabolism in Cancer and Senescence: A Cellular Perspective. Biology. MDPI AG; 2023; 12:989 10.3390/biology12070989
• Orally Administered Curcumin Inhibits Breast Cancer In vivo and Reduces Cell Proliferation In vitro in an Iron Dependent Manner Cite
  Teran-Cabanillas E, Inzunza-Soto M, Leal-León E, Vergara-Jiménez M, López-Moreno S, Cedano-Prieto DM, et al. Orally Administered Curcumin Inhibits Breast Cancer In vivo and Reduces Cell Proliferation In vitro in an Iron Dependent Manner. Current Nutrition & Food Science. Bentham Science Publishers Ltd.; 2023; 19:461-468 10.2174/1573401318666220908122614
• Possible Side Effects of Polyphenols and Their Interactions with Medicines Cite
  Duda-Chodak A, Tarko T. Possible Side Effects of Polyphenols and Their Interactions with Medicines. Molecules. MDPI AG; 2023; 28:2536 10.3390/molecules28062536
• Biomineralogical signatures of breast microcalcifications Cite
  Kunitake JA, Sudilovsky D, Johnson LM, Loh H, Choi S, Morris PG, et al. Biomineralogical signatures of breast microcalcifications. Science Advances. American Association for the Advancement of Science (AAAS); 2023; 9 10.1126/sciadv.ade3152
• Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators Cite
  Wang Y, Ohara T, Chen Y, Hamada Y, Li C, Fujisawa M, et al. Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators. Cancers. MDPI AG; 2023; 15:468 10.3390/cancers15020468
• Puzzling Out Iron Complications in Cancer Drug Resistance Cite
  Abedi M, Rahgozar S. Puzzling Out Iron Complications in Cancer Drug Resistance. Critical Reviews in Oncology/Hematology. Elsevier BV; 2022;:103772 10.1016/j.critrevonc.2022.103772
• Iron Oxide Nanoparticles: The precise strategy for targeted delivery of genes, oligonucleotides and peptides in cancer therapy Cite
  Sachdeva V, Monga A, Vashisht R, Singh D, Singh A, Bedi N. Iron Oxide Nanoparticles: The precise strategy for targeted delivery of genes, oligonucleotides and peptides in cancer therapy. Journal of Drug Delivery Science and Technology. Elsevier BV; 2022;:103585 10.1016/j.jddst.2022.103585
• Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach Cite
  Islam S, Hoque N, Nasrin N, Hossain M, Rizwan F, Biswas K, et al. Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach. Life. MDPI AG; 2022; 12:963 10.3390/life12070963
• Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer Cite
  Buschhaus JM, Rajendran S, Humphries BA, Cutter AC, Muñiz AJ, Ciavattone NG, et al. Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer. Oncogene. Springer Science and Business Media LLC; 2022; 10.1038/s41388-022-02385-9
• Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types. Cite
  Trabolsi A, Arumov A, Yin J, Halmos B, Brodskiy P, Oberley MJ, et al. Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:3120-3120 10.1200/jco.2022.40.16_suppl.3120
• SERUM IRON PARAMETERS AS PROGNOSTIC MARKERS IN BREAST CANCER PATIENTS Cite
  Sawant SS, Varma V, Rani A. SERUM IRON PARAMETERS AS PROGNOSTIC MARKERS IN BREAST CANCER PATIENTS. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. World Wide Journals; 2022;:48-50 10.36106/ijsr/0101707
• Iron imbalance in cancer: Intersection of deficiency and overload Cite
  Basak T, Kanwar RK. Iron imbalance in cancer: Intersection of deficiency and overload. Cancer Medicine. Wiley; 2022; 10.1002/cam4.4761
• The association of dietary antioxidant index (DAI) with breast cancer among Iranian women Cite
  Allahyari P, Ahmadzadeh M, Vahid F, Gholamalizadeh M, Shafaei H, Shekari S, et al. The association of dietary antioxidant index (DAI) with breast cancer among Iranian women. International Journal for Vitamin and Nutrition Research. Hogrefe Publishing Group; 2022; 10.1024/0300-9831/a000750
• Iron chelates in the anticancer therapy Cite
  Szlasa W, Gachowska M, Kiszka K, Rakoczy K, Kiełbik A, Wala K, et al. Iron chelates in the anticancer therapy. Chemical Papers. Springer Science and Business Media LLC; 2021; 10.1007/s11696-021-02001-2
• The Impact of Iron Chelators on the Biology of Cancer Stem Cells Cite
  Szymonik J, Wala K, Górnicki T, Saczko J, Pencakowski B, Kulbacka J. The Impact of Iron Chelators on the Biology of Cancer Stem Cells. International Journal of Molecular Sciences. MDPI AG; 2021; 23:89 10.3390/ijms23010089
• The Regulatory Effects and the Signaling Pathways of Natural Bioactive Compounds on Ferroptosis Cite
  Zhang S, Hu R, Geng Y, Chen K, Wang L, Imam MU. The Regulatory Effects and the Signaling Pathways of Natural Bioactive Compounds on Ferroptosis. Foods. MDPI AG; 2021; 10:2952 10.3390/foods10122952
• Zn, Cu, and Fe Concentrations in Dehydrated Herbs (Thyme, Rosemary, Cloves, Oregano, and Basil) and the Correlation with the Microbial Counts of Listeria monocytogenes and Other Foodborne Pathogens Cite
  García-Galdeano JM, Villalón-Mir M, Medina-Martínez J, Vázquez-Foronda LM, Zamora-Bustillos JG, Agil A, et al. Zn, Cu, and Fe Concentrations in Dehydrated Herbs (Thyme, Rosemary, Cloves, Oregano, and Basil) and the Correlation with the Microbial Counts of Listeria monocytogenes and Other Foodborne Pathogens. Foods. MDPI AG; 2020; 9:1658 10.3390/foods9111658
• Pre-Clinical Insights into the Iron and Breast Cancer Hypothesis Cite
  Thompson HJ, Neil ES, McGinley JN. Pre-Clinical Insights into the Iron and Breast Cancer Hypothesis. Biomedicines. MDPI AG; 2021; 9:1652 10.3390/biomedicines9111652
• The role of ferroptosis‐related genes for overall survival prediction in breast cancer Cite
  Jin L, Gu Y, Zhu Q, Li X, Jiang G. The role of ferroptosis‐related genes for overall survival prediction in breast cancer. Journal of Clinical Laboratory Analysis. Wiley; 2021; 10.1002/jcla.24094
• Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It Cite
  Cosialls E, El Hage R, Dos Santos L, Gong C, Mehrpour M, Hamaï A. Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It. Cells. MDPI AG; 2021; 10:2981 10.3390/cells10112981
• Changes in the Serum Concentrations of Essential Trace Metals in Patients with Benign and Malignant Breast Cancers Cite
  Cao B, Lei Y, Xue H, Liang Y, Liu Y, Xie Q, et al. Changes in the Serum Concentrations of Essential Trace Metals in Patients with Benign and Malignant Breast Cancers. Biological Trace Element Research. Springer Science and Business Media LLC; 2021; 10.1007/s12011-021-02964-z
• Association between trace elements in cancerous and non-cancerous tissues with the risk of breast cancers in western Iran Cite
  Mansouri B, Ramezani Z, Yousefinejad V, Nakhaee S, Azadi N, Khaledi P, et al. Association between trace elements in cancerous and non-cancerous tissues with the risk of breast cancers in western Iran. Environmental Science and Pollution Research. Springer Science and Business Media LLC; 2021; 10.1007/s11356-021-16549-9
• Abstract 2454: Vitamin D-mediated anti-cancer activity involves iron homeostatic balance disruption and oxidative stress induction in breast cancer Cite
  Bajbouj K, Shafarin J, Sahnoon L, Al-Ali A, Muhammad JS, Guraya SY, et al. Abstract 2454: Vitamin D-mediated anti-cancer activity involves iron homeostatic balance disruption and oxidative stress induction in breast cancer. Molecular and Cellular Biology/Genetics. American Association for Cancer Research; 2021; 10.1158/1538-7445.am2021-2454
• Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells Cite
  Shujaa Edin HY, AL-Haj NA, Rasedee A, Banu Alitheen N, Abdul Kadir A, Wun How C, et al. Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells. Saudi Journal of Biological Sciences. Elsevier BV; 2021; 10.1016/j.sjbs.2021.05.043
• Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin Cite
  Yin M, Liu Y, Chen Y. Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin. Free Radical Research. Informa UK Limited; 2021;:1-8 10.1080/10715762.2021.1898604
• Reversing oncogenic transformation with iron chelation Cite
  Abdelaal G, Veuger S. Reversing oncogenic transformation with iron chelation. Oncotarget. Impact Journals, LLC; 2021; 12:106-124 10.18632/oncotarget.27866
• Association between serum iron biomarkers and breast cancer Cite
  Von Holle A, O'Brien KM, Sandler DP, Janicek R, Weinberg CR. Association between serum iron biomarkers and breast cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020;:cebp.0715.2020 10.1158/1055-9965.epi-20-0715
• Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment Cite
  Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Takahashi K, et al. Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-07673-9
• Association between serum iron biomarkers and breast cancer Cite
  Von Holle A, O'Brien KM, Sandler DP, Janicek R, Weinberg CR. Association between serum iron biomarkers and breast cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020;:cebp.0715.2020 10.1158/1055-9965.epi-20-0715
• Iron intake, oxidative stress‐related genes and breast cancer risk Cite
  Chang VC, Cotterchio M, Bondy SJ, Kotsopoulos J. Iron intake, oxidative stress‐related genes and breast cancer risk. International Journal of Cancer. Wiley; 2020; 147:1354-1373 10.1002/ijc.32906
• Micronutrients and Breast Cancer Progression: A Systematic Review Cite
  Cuenca-Micó O, Aceves C. Micronutrients and Breast Cancer Progression: A Systematic Review. Nutrients. MDPI AG; 2020; 12:3613 10.3390/nu12123613
• Serum Iron Status and the Risk of Breast Cancer in Europeans: A 2-Sample Mendelian Randomisation Study Cite
  Hou C, Hou Q, Xie X, Wang H, Chen Y, Lu T, et al. Serum Iron Status and the Risk of Breast Cancer in Europeans: A 2-Sample Mendelian Randomisation Study. Research Square; 2020; 10.21203/rs.3.rs-57485/v1
• Nutrient Intake through Childhood and Early Menarche Onset in Girls: Systematic Review and Meta-Analysis Cite
  Nguyen NTK, Fan H, Tsai M, Tung T, Huynh QTV, Huang S, et al. Nutrient Intake through Childhood and Early Menarche Onset in Girls: Systematic Review and Meta-Analysis. Nutrients. MDPI AG; 2020; 12:2544 10.3390/nu12092544
• Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment Cite
  Cheng M, Liu P, Xu LX. Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment. Journal of Inorganic Biochemistry. Elsevier BV; 2020; 210:111159 10.1016/j.jinorgbio.2020.111159
• Analysis of trace elements in the fingernails of breast cancer patients using instrumental neutron activation analysis Cite
  Huynh PT, Tran TPN, Dinh BT, Nguyen LTT, Truong LTH, Tran AT, et al. Analysis of trace elements in the fingernails of breast cancer patients using instrumental neutron activation analysis. Journal of Radioanalytical and Nuclear Chemistry. Springer Science and Business Media LLC; 2020; 324:663-671 10.1007/s10967-020-07093-w
• Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221) Cite
  Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, et al. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 38:804-814 10.1200/jco.19.01203
• Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis Cite
  Chang VC, Cotterchio M, Khoo E. Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-5642-0
• Serum erythropoietin levels, breast cancer and breast cancer-initiating cells Cite
  Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, et al. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1100-9
• Lipid accumulation in human breast cancer cells injured by iron depletors Cite
  De Bortoli M, Taverna E, Maffioli E, Casalini P, Crisafi F, Kumar V, et al. Lipid accumulation in human breast cancer cells injured by iron depletors. Journal of Experimental & Clinical Cancer Research. Springer Science and Business Media LLC; 2018; 37 10.1186/s13046-018-0737-z
• Cadmium, arsenic, selenium and iron– Implications for tumor progression in breast cancer Cite
  Jablonska E, Socha K, Reszka E, Wieczorek E, Skokowski J, Kalinowski L, et al. Cadmium, arsenic, selenium and iron– Implications for tumor progression in breast cancer. Environmental Toxicology and Pharmacology. Elsevier BV; 2017; 53:151-157 10.1016/j.etap.2017.05.014
• Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells Cite
  JIANG X, ELLIOTT RL. Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells. Anticancer Research. International Institute of Anticancer Research; 2017; 37:2297-2305 10.21873/anticanres.11567
• Reduced cancer mortality at high altitude: The role of glucose, lipids, iron and physical activity Cite
  Thiersch M, Swenson E, Haider T, Gassmann M. Reduced cancer mortality at high altitude: The role of glucose, lipids, iron and physical activity. Experimental Cell Research. Elsevier BV; 2017; 356:209-216 10.1016/j.yexcr.2017.03.048
• Iron chelators target both proliferating and quiescent cancer cells Cite
  Fryknäs M, Zhang X, Bremberg U, Senkowski W, Olofsson MH, Brandt P, et al. Iron chelators target both proliferating and quiescent cancer cells. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep38343
• Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer Cite
  Chen B, Dai D, Tang H, Ai X, Chen X, Zhang X, et al. Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0165133 10.1371/journal.pone.0165133
• Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life Cite
  Kanuri G, Sawhney R, Varghese J, Britto M, Shet A. Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0163817 10.1371/journal.pone.0163817
• Dietary iron intake and breast cancer risk: modulation by an antioxidant supplementation Cite
  Diallo A, Deschasaux M, Partula V, Latino-Martel P, Srour B, Hercberg S, et al. Dietary iron intake and breast cancer risk: modulation by an antioxidant supplementation. Oncotarget. Impact Journals, LLC; 2016; 7:79008-79016 10.18632/oncotarget.12592
• Iron participated in breast cancer chemoresistance by reinforcing IL-6 paracrine loop Cite
  Li J, He K, Liu P, Xu LX. Iron participated in breast cancer chemoresistance by reinforcing IL-6 paracrine loop. Biochemical and Biophysical Research Communications. Elsevier BV; 2016; 475:154-160 10.1016/j.bbrc.2016.05.064
• Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling Cite
  Liu P, He K, Song H, Ma Z, Yin W, Xu LX. Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling. Journal of Inorganic Biochemistry. Elsevier BV; 2016; 160:40-48 10.1016/j.jinorgbio.2016.04.014
• Iron Chelating and Antioxidant Activities and Cytotoxicity Effect of the Pistachio (Pistachio vera L.) hull and kernel Extracts in the A549, HT29 and MCF-7 Cancerous Cell lines Cite
  F D, SJ F, A M, F S. Iron Chelating and Antioxidant Activities and Cytotoxicity Effect of the Pistachio (Pistachio vera L.) hull and kernel Extracts in the A549, HT29 and MCF-7 Cancerous Cell lines. International Journal of Clinical Pharmacology & Toxicology. SciDoc Publishers LLC; 2016;:195-201 10.19070/2167-910x-1600033
• Formation of Malondialdehyde, 4-Hydroxynonenal, and 4-Hydroxyhexenal during in Vitro Digestion of Cooked Beef, Pork, Chicken, and Salmon Cite
  Steppeler C, Haugen J, Rødbotten R, Kirkhus B. Formation of Malondialdehyde, 4-Hydroxynonenal, and 4-Hydroxyhexenal during in Vitro Digestion of Cooked Beef, Pork, Chicken, and Salmon. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2016; 64:487-496 10.1021/acs.jafc.5b04201
• Iron metabolism and iron supplementation in cancer patients Cite
  Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, et al. Iron metabolism and iron supplementation in cancer patients. Wiener klinische Wochenschrift. Springer Science and Business Media LLC; 2015; 127:907-919 10.1007/s00508-015-0842-3
• Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death Cite
  BURANRAT B, CONNOR JR. Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death. Oncology Reports. Spandidos Publications; 2015; 34:2790-2796 10.3892/or.2015.4250
• Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients Cite
  Mannello F, Tonti GA, Medda V, Simone P, Darbre PD. Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients. Journal of Applied Toxicology. Wiley; 2011; 31:262-269 10.1002/jat.1641
• Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer Cite
  Mittal R, Chaudhry N, Pathania S, Mukherjee T. Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer. Current Pharmaceutical Biotechnology. Bentham Science Publishers Ltd.; 2014; 15:1141-1157 10.2174/1389201015666141126121240
• The Association between Postdiagnosis Dietary Supplement Use and Total Mortality Differs by Diet Quality among Older Female Cancer Survivors Cite
  Inoue-Choi M, Greenlee H, Oppeneer SJ, Robien K. The Association between Postdiagnosis Dietary Supplement Use and Total Mortality Differs by Diet Quality among Older Female Cancer Survivors. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:865-875 10.1158/1055-9965.epi-13-1303
• Iron-fortified flour: can it induce lipid peroxidation? Cite
  Abtahi M, Neyestani TR, Pouraram H, Siassi F, Dorosty AR, Elmadfa I, et al. Iron-fortified flour: can it induce lipid peroxidation?. International Journal of Food Sciences and Nutrition. Informa UK Limited; 2014; 65:649-654 10.3109/09637486.2014.898254
• Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation Cite
  Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SVN, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. Journal of Clinical Investigation. American Society for Clinical Investigation; 2014; 124:617-630 10.1172/jci72931
• Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin Cite
  CHEKHUN VF, LUKYANOVA NY, BURLAKA AP, BEZDENEZHNYKH NA, SHPYLEVA SI, TRYNDYAK VP, et al. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin. International Journal of Oncology. Spandidos Publications; 2013; 43:1481-1486 10.3892/ijo.2013.2063
• A link between premenopausal iron deficiency and breast cancer malignancy Cite
  Jian J, Yang Q, Shao Y, Axelrod D, Smith J, Singh B, et al. A link between premenopausal iron deficiency and breast cancer malignancy. BMC Cancer. Springer Science and Business Media LLC; 2013; 13 10.1186/1471-2407-13-307
• Role of Ca, Fe, Cu and Zn in breast cancer: study by X-ray fluorescence techniques and immunohistochemical analysis Cite
  Silva MP, Silva DM, Conceição ALC, Ribeiro-Silva A, Poletti ME. Role of Ca, Fe, Cu and Zn in breast cancer: study by X-ray fluorescence techniques and immunohistochemical analysis. X-Ray Spectrometry. Wiley; 2013; 42:303-311 10.1002/xrs.2470
• Dietary Iron and Heme Iron Intake and Risk of Breast Cancer: A Prospective Cohort Study Cite
  Kabat GC, Miller AB, Jain M, Rohan TE. Dietary Iron and Heme Iron Intake and Risk of Breast Cancer: A Prospective Cohort Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2007; 16:1306-1308 10.1158/1055-9965.epi-07-0086
• Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages Cite
  Alkhateeb AA, Han B, Connor JR. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 137:733-744 10.1007/s10549-012-2405-x
• Continued studies on determination of selected metals in oysters from Southwest Louisiana by inductively coupled plasma-optical emission spectrometry Cite
  Sneddon EJ, Hardaway CJ, Sneddon J, Zhang N. Continued studies on determination of selected metals in oysters from Southwest Louisiana by inductively coupled plasma-optical emission spectrometry. Microchemical Journal. Elsevier BV; 2013; 108:239-240 10.1016/j.microc.2012.11.004
• The effect of dietary zinc - and polyphenols intake on DMBA-induced mammary tumorigenesis in rats Cite
  Bobrowska-Korczak B, Skrajnowska D, Tokarz A. The effect of dietary zinc - and polyphenols intake on DMBA-induced mammary tumorigenesis in rats. Journal of Biomedical Science. Springer Science and Business Media LLC; 2012; 19:43 10.1186/1423-0127-19-43
• Dietary Supplements and Mortality Rate in Older Women Cite
  Mursu J. Dietary Supplements and Mortality Rate in Older Women. Archives of Internal Medicine. American Medical Association (AMA); 2011; 171:1625 10.1001/archinternmed.2011.445
• Multivitamin Use and the Risk of Mortality and Cancer Incidence: The Multiethnic Cohort Study Cite
  Park S, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin Use and the Risk of Mortality and Cancer Incidence: The Multiethnic Cohort Study. American Journal of Epidemiology. Oxford University Press (OUP); 2011; 173:906-914 10.1093/aje/kwq447
• Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health–AARP Diet and Health Study Cite
  Kabat GC, Cross AJ, Park Y, Schatzkin A, Hollenbeck AR, Rohan TE, et al. Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health–AARP Diet and Health Study. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2010; 92:1478-1483 10.3945/ajcn.2010.29753
• The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells Cite
  Rao VA, Klein SR, Agama KK, Toyoda E, Adachi N, Pommier Y, et al. The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells. Cancer Research. American Association for Cancer Research (AACR); 2009; 69:948-957 10.1158/0008-5472.can-08-1437
• Role of ferritin alterations in human breast cancer cells Cite
  Shpyleva SI, Tryndyak VP, Kovalchuk O, Starlard-Davenport A, Chekhun VF, Beland FA, et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 126:63-71 10.1007/s10549-010-0849-4
• Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults Cite
  Wu T. Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Annals of Epidemiology. Elsevier BV; 2004; 14:195-201 10.1016/s1047-2797(03)00119-4
• Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study Cite
  Kallianpur AR, Lee S, Gao Y, Lu W, Zheng Y, Ruan Z, et al. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2007; 107:123-132 10.1007/s10549-007-9538-3
• Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer Cite
  Cui Y, Vogt S, Olson N, Glass AG, Rohan TE. Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2007; 16:1682-1685 10.1158/1055-9965.epi-07-0187